DTL
LFCR icon

Dynamic Technology Lab’s Lifecore Biomedical LFCR Stock Holding History

Dynamic Technology Lab’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,375
Closed -$75.8K – 907
2026
Q1 		$75.8K Buy
+20,375
New +$141K 0.01% 804
2017
Q4 		– Sell
-10,913
Closed -$141K – 1178
2017
Q3 		$141K Buy
+10,913
New +$144K 0.02% 949
2016
Q4 		– Sell
-10,757
Closed -$144K – 1032
2016
Q3 		$144K Buy
+10,757
New +$130K 0.04% 779
2015
Q3 		– Sell
-11,382
Closed -$164K – 945
2015
Q2 		$164K Buy
+11,382
New +$164K 0.06% 656
2015
Q1 		– Sell
-14,951
Closed -$206K – 782
2014
Q4 		$206K Buy
+14,951
New +$193K 0.1% 473

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Dynamic Technology Lab's LFCR Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Lifecore Biomedical (LFCR) in Q2 2026, closing a stake of 20,375 shares — an estimated $75.8K sold.

Dynamic Technology Lab first reported a position in LFCR in Q4 2014 and held it in 5 quarters. The position peaked at $206K in Q4 2014. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Dynamic Technology Lab reported no remaining Lifecore Biomedical position as of Q2 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 20,375 Lifecore Biomedical shares in Q2 2026, an estimated $75.8K.
  • Dynamic Technology Lab first reported a position in Lifecore Biomedical in Q4 2014 and held it in 5 quarters.
  • Dynamic Technology Lab's Lifecore Biomedical position peaked at $206K in Q4 2014.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.